title: Psychologic and psychiatric aspects of gastrointestinal disease.
abstract: There has been an explosion in understanding of the psychosocial concomitants of functional gastrointestinal disorders. Detecting psychologic disturbance and eliciting a history of physical or sexual abuse are critical in suggesting comprehensive and efficacious treatment strategies for these patients. The challenge is to define further the use of psychopharmacologic agents, including the newer antidepressants, anticonvulsants, and anxiolytic agents, in the treatment of chronic functional gastrointestinal disorders. Further research to evaluate the usefulness of various forms of psychotherapeutic and behavioral interventions needs to be undertaken. Establishing a multicomponent treatment program delivered by a team of caregivers, each bringing their unique skills (internist, psychiatrist, psychologist, and others) to patients, must be based on further research on the efficacy of these modalities as opposed to empiric treatment.
authors.affiliation: Department of Medicine, Mayo Clinic Scottsdale, Arizona, USA. Olden.Kevin@mayo.edu
authors.forename: K W
authors.initials: KW
authors.lastname: Olden
authors.forename: D A
authors.initials: DA
authors.lastname: Drossman
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D003131:Combined Modality Therapy; D005767:Gastrointestinal Diseases / Q000503:physiopathology / Q000523:psychology* / Q000628:therapy; D006801:Humans; D010348:Patient Care Team; D011602:Psychophysiologic Disorders / Q000175:diagnosis / Q000628:therapy; D011613:Psychotherapy; D012742:Sex Offenses; D014754:Violence
chemical_list: D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents